Cargando…
Live-single-cell phenotypic cancer biomarkers-future role in precision oncology?
The promise of precision and personalized medicine is rooted in accurate, highly sensitive, and specific disease biomarkers. This is particularly true for cancer-a disease characterized by marked tumor heterogeneity and diverse molecular signatures. Although thousands of biomarkers have been describ...
Autores principales: | Sant, Grannum R., Knopf, Kevin B., Albala, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871838/ https://www.ncbi.nlm.nih.gov/pubmed/29872705 http://dx.doi.org/10.1038/s41698-017-0025-y |
Ejemplares similares
-
Evidence‐Based Development and Clinical Use of Precision Oncology Therapeutics
por: Comment, Leah A., et al.
Publicado: (2020) -
Data Sharing, Clinical Trials, and Biomarkers in Precision Oncology: Challenges, Opportunities, and Programs at the Department of Veterans Affairs
por: Fiore, LD, et al.
Publicado: (2017) -
Giving Up on Precision Oncology? Not So Fast!
por: Warner, JL
Publicado: (2017) -
Precision oncology for patients with advanced cancer: the challenges of malignant snowflakes
por: Kurzrock, Razelle, et al.
Publicado: (2015) -
Artificial intelligence for precision oncology: beyond patient stratification
por: Azuaje, Francisco
Publicado: (2019)